Image may be NSFW.
Clik here to view.
Clik here to view.
Isotechnika receives positive scientific advice in Europe for voclosporin
Isotechnika Pharma (TSX:ISA) said it has received positive Scientific Advice from the European Medicines Agency for a proposed Phase 3 clinical trial protocol of its drug, voclosporin, after the agency...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Isotechnika releases shareholder letter
In a letter to shareholders issued today, Isotechnika Pharma (TSX:ISA) CEO Dr. Robert Foster explains the company’s decision to move its voclosporin drug into Phase 3 clinical trials for the prevention...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Glickman swinging for the fence again in Isotechnika merger
Richard Glickman is poised to hit another home run with the proposed merger of his closely-held Aurinia Pharmaceuticals and Isotechnika Pharma (TSX:ISA) to create a global nephrology leader. Richard...
View Article
More Pages to Explore .....
